FR2410043A1 - Nouveau vaccin contre la mammite de la vache et son procede de production - Google Patents
Nouveau vaccin contre la mammite de la vache et son procede de productionInfo
- Publication number
- FR2410043A1 FR2410043A1 FR7828133A FR7828133A FR2410043A1 FR 2410043 A1 FR2410043 A1 FR 2410043A1 FR 7828133 A FR7828133 A FR 7828133A FR 7828133 A FR7828133 A FR 7828133A FR 2410043 A1 FR2410043 A1 FR 2410043A1
- Authority
- FR
- France
- Prior art keywords
- production process
- vaccine against
- new vaccine
- cow mammitis
- against cow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/823—Bacterial vaccine for bovine species, e.g. cattle
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
L'INVENTION A TRAIT AU DOMAINE DE L'IMMUNOLOGIE. ELLE CONCERNE UN PROCEDE DE PRODUCTION D'UN VACCIN A PARTIR D'UNE SOUCHE DE STAPHYLOCOCCUS AUREUS OU DE STAPHYLOCOCCUS EPIDERMIDIS. LE VACCIN DE L'INVENTION EST EFFICACE POUR LE TRAITEMENT PREVENTIF ET CURATIF DE MALADIES INFECTIEUSES TELLES QUE LA MAMMITE DE LA VACHE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11842677A JPS5452794A (en) | 1977-09-30 | 1977-09-30 | Extracting of polysacchride from capusle containing epidermis staphylococus |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2410043A1 true FR2410043A1 (fr) | 1979-06-22 |
FR2410043B1 FR2410043B1 (fr) | 1983-09-09 |
Family
ID=14736342
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7828133A Granted FR2410043A1 (fr) | 1977-09-30 | 1978-10-02 | Nouveau vaccin contre la mammite de la vache et son procede de production |
FR8022285A Granted FR2468372A1 (fr) | 1977-09-30 | 1980-10-17 | Nouveau vaccin contre les maladies infectieuses chez les bovins et son procede de production |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8022285A Granted FR2468372A1 (fr) | 1977-09-30 | 1980-10-17 | Nouveau vaccin contre les maladies infectieuses chez les bovins et son procede de production |
Country Status (4)
Country | Link |
---|---|
US (1) | US4197290A (fr) |
JP (1) | JPS5452794A (fr) |
FR (2) | FR2410043A1 (fr) |
GB (1) | GB2009771B (fr) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0135951A2 (fr) * | 1983-08-31 | 1985-04-03 | The Stolle Research And Development Corporation | Méthode pour produire un vaccin polyvalent anti-mastite |
EP0302781A1 (fr) * | 1987-08-03 | 1989-02-08 | Institut Pasteur | Procédé d'obtention de polyosides capsulaires de staphylocoques, applications de ces polyosides et souches pour la mise en oeuvre du procédé |
EP0436648A1 (fr) * | 1988-09-28 | 1991-07-17 | Brigham And Women's Hospital | Antigene de l'adhesine polysaccharide capsulaire, sa preparation, sa purification et son utilisation |
US7252828B2 (en) | 1998-07-15 | 2007-08-07 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for staphylococcal infections |
US7723087B2 (en) | 2002-11-12 | 2010-05-25 | The Brigham And Women's Hospital, Inc. | Nucleic acid molecules for enhanced production of a bacterial polysaccharide and methods of use thereof |
US7786255B2 (en) | 2004-04-21 | 2010-08-31 | The Bringham and Women's Hospital, Inc. | Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof |
US8492364B2 (en) | 2008-07-21 | 2013-07-23 | The Brigham And Women's Hospital, Inc. | Methods and compositions relating to synthetic β-1,6 glucosamine oligosaccharides |
US10919956B2 (en) | 2002-11-12 | 2021-02-16 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for staphylococcal infections |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4327082A (en) * | 1979-07-12 | 1982-04-27 | Adcock-Ingram Laboratories Limited | Mastitis vaccination |
US4425330A (en) | 1981-05-20 | 1984-01-10 | Cornell Research Foundation, Inc. | Bovine mastitis vaccine and method for detecting efficacy thereof |
DE3345864A1 (de) * | 1983-12-19 | 1985-06-27 | Egbert Frh. von 8000 München Malsen-Ponickau | Impfstoff und verfahren zu seiner herstellung |
JPS62165286U (fr) * | 1986-04-07 | 1987-10-20 | ||
US5034515A (en) * | 1987-09-22 | 1991-07-23 | Wisconsin Alumni Research Foundation | Staphylococcal fibronectin receptor, monoclonal antibodies thereto and methods of use |
US7279162B1 (en) * | 1990-10-22 | 2007-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection |
US5955074A (en) * | 1990-10-22 | 1999-09-21 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Directed human immune globulin for the prevention and treatment of staphylococcal infections |
US5571511A (en) * | 1990-10-22 | 1996-11-05 | The U.S. Government | Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
US20080139789A1 (en) * | 1990-10-22 | 2008-06-12 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Isolated Broadly Reactive Opsonic Immunoglobulin for Treating a Pathogenic Coagulase-Negative Staphylococcus Infection |
WO1993009811A1 (fr) * | 1991-11-22 | 1993-05-27 | Univax Biologics, Inc. | ANTIGENES DE SURFACE DU TYPE I ET DU TYPE II, ASSOCIES AU $i(STAPHYLOCOCCUS EPIDERMIDIS) |
US5980908A (en) * | 1991-12-05 | 1999-11-09 | Alfa Laval Ab | Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment |
JPH08504167A (ja) * | 1992-02-25 | 1996-05-07 | アメリカ合衆国 | スタフィロコーカス感染の予防及び処理のための指図されたヒト免疫グロブリン |
US6610293B1 (en) | 1997-06-16 | 2003-08-26 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine | Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
US7250494B2 (en) * | 1998-06-15 | 2007-07-31 | Biosynexus Incorporated | Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
US6984381B2 (en) | 2002-07-05 | 2006-01-10 | The United States Of America As Represented By The Secretary Of Agriculture | Vaccine for the prevention of bacterial infection of the bovine mammary gland |
MX2007003400A (es) | 2004-09-22 | 2008-03-04 | Glaxosmithkline Biolog Sa | Composicion inmunogena. |
BRPI0710210A2 (pt) | 2006-03-30 | 2011-05-24 | Glaxomithkline Biolog S A | composição imunogênica, vacina, métodos para preparar a vacina, e para prevenir ou tratar infecção estafilocócica, uso da composição imunogênica, e, processo para conjugar oligassacarìdeo ou polissacarìdeo capsular |
EP2341929B1 (fr) | 2008-10-06 | 2017-01-25 | University Of Chicago | Compositions et procédés associés aux protéines bactériennes emp |
TW201043267A (en) * | 2009-03-19 | 2010-12-16 | Intervet Int Bv | In situ constituting a vaccine for administration to a predetermined herd of animals |
GB0913680D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
GB0913681D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
BR112012009014B8 (pt) | 2009-09-30 | 2022-10-04 | Novartis Ag | Processo para preparar conjugado de polissacarídeo capsular de s. aureus tipo 5 ou tipo 8 e molécula de transporte crm197, conjugado e composição imunogênica |
EP3199177A1 (fr) | 2009-10-30 | 2017-08-02 | GlaxoSmithKline Biologicals S.A. | Purification de saccharides capsulaires de staphylococcus aureus de type 5 et de type 8 |
EP2655389A2 (fr) | 2010-12-24 | 2013-10-30 | Novartis AG | Composés |
EP2755683B1 (fr) | 2011-09-14 | 2019-04-03 | GlaxoSmithKline Biologicals SA | Procédés de production de glycoconjugués de saccharide-protéine |
WO2013068949A1 (fr) | 2011-11-07 | 2013-05-16 | Novartis Ag | Molécule porteuse comprenant un antigène spr0096 et un antigène spr2021 |
GB201121301D0 (en) | 2011-12-12 | 2012-01-25 | Novartis Ag | Method |
MX2014014067A (es) | 2012-05-22 | 2015-02-04 | Novartis Ag | Conjugado de serogrupo x de meningococo. |
CA3088851A1 (fr) * | 2018-01-05 | 2019-07-11 | Azitra Inc | Souches auxotrophes de bacterie staphylococcus |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL262599A (fr) * | 1900-01-01 | |||
NL278429A (fr) * | 1900-01-01 | |||
GB925124A (en) * | 1960-03-21 | 1963-05-01 | Parke Davis & Co | Staphylococcal vaccine |
DE1154234B (de) * | 1960-03-21 | 1963-09-12 | Parke Davis & Co | Verfahren zur Herstellung einer Staphylococcenvaccine |
FR1334930A (fr) * | 1961-03-20 | 1963-08-16 | Parke Davis & Co | Procédé de production d'un antigène nouveau par extraction de culture de staphylocoques |
DE1185335B (de) * | 1961-05-15 | 1965-01-14 | Parke Davis & Co | Verfahren zur Herstellung von neuen Staphylococcen-Antigenen |
US3269913A (en) * | 1962-05-11 | 1966-08-30 | Parke Davis & Co | Staphylococcal-immunizing products and methods for their production |
GB995338A (en) * | 1963-09-20 | 1965-06-16 | Parke Davis & Co | Polysaccharides and methods for their production |
JPS5520268B2 (fr) * | 1972-07-15 | 1980-05-31 |
-
1977
- 1977-09-30 JP JP11842677A patent/JPS5452794A/ja active Granted
-
1978
- 1978-09-29 GB GB7838618A patent/GB2009771B/en not_active Expired
- 1978-09-29 US US05/947,103 patent/US4197290A/en not_active Expired - Lifetime
- 1978-10-02 FR FR7828133A patent/FR2410043A1/fr active Granted
-
1980
- 1980-10-17 FR FR8022285A patent/FR2468372A1/fr active Granted
Non-Patent Citations (2)
Title |
---|
CA1974 * |
EXBK/75 * |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0135951A3 (en) * | 1983-08-31 | 1986-05-07 | The Stolle Research And Development Corporation | Anti-mastitis polyvalent vaccine, method of administration and method for production thereof |
EP0135951A2 (fr) * | 1983-08-31 | 1985-04-03 | The Stolle Research And Development Corporation | Méthode pour produire un vaccin polyvalent anti-mastite |
EP0302781A1 (fr) * | 1987-08-03 | 1989-02-08 | Institut Pasteur | Procédé d'obtention de polyosides capsulaires de staphylocoques, applications de ces polyosides et souches pour la mise en oeuvre du procédé |
FR2619122A1 (fr) * | 1987-08-03 | 1989-02-10 | Pasteur Institut | Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede |
US4902616A (en) * | 1987-08-03 | 1990-02-20 | Institut Pasteur | Process for the preparation of capsular polysaccharides of staphylococci, the polysaccharides obtained, uses of these polysaccharides and strains for carrying out of the process |
EP0436648A1 (fr) * | 1988-09-28 | 1991-07-17 | Brigham And Women's Hospital | Antigene de l'adhesine polysaccharide capsulaire, sa preparation, sa purification et son utilisation |
EP0436648A4 (en) * | 1988-09-28 | 1991-11-13 | Brigham And Women's Hospital | Capsular polysaccharide adhesin antigen, preparation, purification and use |
US6743431B2 (en) | 1988-09-28 | 2004-06-01 | The Brigham And Women's Hospital, Inc. | Capsular polysaccharide adhesin antigen, preparation, purification and use |
US7015007B2 (en) | 1988-09-28 | 2006-03-21 | The Brigham And Women's Hospital, Inc. | Capsular polysaccharide adhesin antigen, preparation, purification and use |
US8663654B2 (en) | 1998-07-15 | 2014-03-04 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for staphylococcal infections |
US7252828B2 (en) | 1998-07-15 | 2007-08-07 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for staphylococcal infections |
US7723087B2 (en) | 2002-11-12 | 2010-05-25 | The Brigham And Women's Hospital, Inc. | Nucleic acid molecules for enhanced production of a bacterial polysaccharide and methods of use thereof |
US10919956B2 (en) | 2002-11-12 | 2021-02-16 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for staphylococcal infections |
US7786255B2 (en) | 2004-04-21 | 2010-08-31 | The Bringham and Women's Hospital, Inc. | Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof |
US9458227B2 (en) | 2004-04-21 | 2016-10-04 | The Brigham And Women's Hospital, Inc. | Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof |
US10017563B2 (en) | 2004-04-21 | 2018-07-10 | The Brigham And Women's Hospital, Inc. | Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof |
US10906962B2 (en) | 2004-04-21 | 2021-02-02 | The Brigham And Women's Hospital, Inc. | Poly-n-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof |
US8492364B2 (en) | 2008-07-21 | 2013-07-23 | The Brigham And Women's Hospital, Inc. | Methods and compositions relating to synthetic β-1,6 glucosamine oligosaccharides |
US9474806B2 (en) | 2008-07-21 | 2016-10-25 | The Brigham And Women's Hospital, Inc. | Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides |
US10034927B2 (en) | 2008-07-21 | 2018-07-31 | The Brigham And Women's Hospital, Inc. | Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides |
US11123416B2 (en) | 2008-07-21 | 2021-09-21 | The Brigham And Women's Hospital, Inc. | Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides |
Also Published As
Publication number | Publication date |
---|---|
JPS5611436B2 (fr) | 1981-03-14 |
FR2410043B1 (fr) | 1983-09-09 |
FR2468372A1 (fr) | 1981-05-08 |
GB2009771A (en) | 1979-06-20 |
US4197290A (en) | 1980-04-08 |
FR2468372B1 (fr) | 1983-10-14 |
GB2009771B (en) | 1982-07-14 |
JPS5452794A (en) | 1979-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2410043A1 (fr) | Nouveau vaccin contre la mammite de la vache et son procede de production | |
FR2445146A1 (fr) | Medicament a prise orale contenant une substance inhibitrice de l'inflammation et un ou plusieurs phospholipides | |
FR2412505A1 (fr) | Procede pour la desodorisation de boues, en particulier de boues de clarification | |
DE69133516D1 (de) | Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen | |
ATE130762T1 (de) | Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen. | |
ATA242288A (de) | Dosierungsform für die behandlung kardiovaskulärer erkrankungen | |
PT64840A (fr) | Procede de preparation d'esteres aralquiliques d'acide 1,4-dihydrapiridinocarboxilique a effet coronaire et antihypertensive application des memes pour la preparation de compositions pharmaceutiques a effet coronaire et antihypertensive et application de ces compositions pharmaceutiques pour le traitement de maladies de lacirculation sanguine | |
BE804433A (fr) | Procede et installation pour le traitement de champignons de paris appertises et champignons ainsi traites. | |
RU94020410A (ru) | Способ лечения или профилактики рвоты у млекопитающих и человека с использованием некоторых хинуклидиновых, пиперидиновых, азанорборнановых, этилендиаминовых производных и родственных им соединений | |
FR2453136A1 (fr) | Analogue cyclique d'un peptide naturel stimulant la phagocytose : le threonyl-cyclo-(-ne-lysyl-propyl-arginyl-) et son procede de preparation | |
DE3873855D1 (de) | Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten. | |
DE69602412D1 (de) | Ophthalmische Zubereitung zur Behandlung oder Prävention von trockenem Auge und Krankheiten, die dadurch verursacht werden, enthaltend 12-Sulfodehydroabietsäure | |
BE875918A (fr) | Ensemble de traitement a acheminement axial des produits de recolte pour moissonneuse-batteuse | |
FR2362587A1 (fr) | Agents antimicrobie | |
ES2044170T3 (es) | Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen. | |
FR2614203B1 (fr) | Composition pharmaceutique pour le traitement des maladies de la peau et son procede de preparation. | |
FR2392032A1 (fr) | 8-n-glucuronide de 8-amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoleine, son procede de preparation et son application en therapeutique | |
FR2600256B1 (fr) | Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus | |
FR2437832A1 (fr) | Medicament a base de p-tolyl diiodomethylsulfone utile notamment pour le traitement des infections cutanees provoquees par les levures et les champignons | |
FR2380778A1 (fr) | Compositions pharmaceutiques contenant des acides oxaniliques substitues ou leurs esters | |
FR2444045A1 (fr) | Sels d'argent d'acide phosphanilique, leur procede de production, composition antibacterienne les contenant et leur application a l'inhibition de la croissance des bacteries | |
GR75239B (fr) | ||
FR2433944A1 (fr) | Formulations et compositions pharmaceutiques pour le traitement des plaies a base d'allantoine | |
FR1483245A (fr) | Installation pour la taille et les traitements des plantes, notamment des azalées de toutes familles, ainsi que les plantes telles qu'azalées traitées | |
FR2532660B1 (fr) | Procede de traitement des minerais galeneux ou plomb-zinc sulfures ou des concentres sulfures ou de leurs melanges |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |